168 related articles for article (PubMed ID: 14602230)
1. Detection of HLA-G5 secreting cells.
Rebmann V; Busemann A; Lindemann M; Grosse-Wilde H
Hum Immunol; 2003 Nov; 64(11):1017-24. PubMed ID: 14602230
[TBL] [Abstract][Full Text] [Related]
2. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
3. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
4. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
6. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.
Le Rond S; Le Maoult J; Créput C; Menier C; Deschamps M; Le Friec G; Amiot L; Durrbach A; Dausset J; Carosella ED; Rouas-Freiss N
Eur J Immunol; 2004 Mar; 34(3):649-660. PubMed ID: 14991594
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
8. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
9. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma.
Rizzo R; Mapp CE; Melchiorri L; Maestrelli P; Visentin A; Ferretti S; Bononi I; Miotto D; Baricordi OR
J Allergy Clin Immunol; 2005 Mar; 115(3):508-13. PubMed ID: 15753897
[TBL] [Abstract][Full Text] [Related]
10. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1.
Kanai T; Fujii T; Kozuma S; Miki A; Yamashita T; Hyodo H; Unno N; Yoshida S; Taketani Y
J Reprod Immunol; 2003 Dec; 60(2):85-96. PubMed ID: 14638437
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells.
Keskinen P; Ronni T; Matikainen S; Lehtonen A; Julkunen I
Immunology; 1997 Jul; 91(3):421-9. PubMed ID: 9301532
[TBL] [Abstract][Full Text] [Related]
12. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture.
Kanai T; Fujii T; Kozuma S; Yamashita T; Miki A; Kikuchi A; Taketani Y
Mol Hum Reprod; 2001 Feb; 7(2):195-200. PubMed ID: 11160846
[TBL] [Abstract][Full Text] [Related]
13. B cell activation regulates exosomal HLA production.
Arita S; Baba E; Shibata Y; Niiro H; Shimoda S; Isobe T; Kusaba H; Nakano S; Harada M
Eur J Immunol; 2008 May; 38(5):1423-34. PubMed ID: 18425730
[TBL] [Abstract][Full Text] [Related]
14. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
[TBL] [Abstract][Full Text] [Related]
15. Secretion of sHLA-G molecules in malignancies.
Rebmann V; Regel J; Stolke D; Grosse-Wilde H
Semin Cancer Biol; 2003 Oct; 13(5):371-7. PubMed ID: 14708717
[TBL] [Abstract][Full Text] [Related]
16. Impact of blood processing on estimation of soluble HLA-G.
Poláková K; Bandžuchová E; Russ G
Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
[TBL] [Abstract][Full Text] [Related]
17. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
[TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
[TBL] [Abstract][Full Text] [Related]
19. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4⁺ T cells and macrophages.
Lombardelli L; Aguerre-Girr M; Logiodice F; Kullolli O; Casart Y; Polgar B; Berrebi A; Romagnani S; Maggi E; Le Bouteiller P; Piccinni MP
J Immunol; 2013 Oct; 191(7):3651-62. PubMed ID: 23997222
[TBL] [Abstract][Full Text] [Related]
20. Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival.
Monneret G; Voirin N; Krawice-Radanne I; Bohé J; Lepape A; Rouas-Freiss N; Carosella ED
Crit Care Med; 2007 Aug; 35(8):1942-7. PubMed ID: 17581490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
